Syneos Health Wins Society for Clinical Research Sites Eagle Award for Fourth Consecutive Year
“We are honored that sites have consistently selected
This year’s winners were selected by investigative sites – nearly 10,000 research sites in 47 countries – who voted for the CRO they believe best demonstrates a strong commitment to site partnerships. Selection criteria included availability of qualified staff to support sites, willingness to collaborate, protocol design and execution, financial consideration and partnering with sites for future work.
“Syneos Health has won the SCRS Eagle Award for three previous years in the CRO category, and this fourth win is in a very different landscape," said
Learn more about Syneos Heath’s site and patient engagement programs, including the Company’s Catalyst Site Program that delivers proven predictability in clinical trial delivery for for Early Phase, Oncology, Psychiatry, Vaccine, Ophthalmology and Post-Operative Pain and Pain trials: syneoshealth.com/catalyst
|Investor Relations Contact:||Press/Media Contact:|
|Senior Vice President, Investor Relations||Vice President,
|+1 919 745 2745||+1 202 210 5992|
Source: Syneos Health, Inc.